ライフサイエンスコーパス: bacterial overgrowth

1 actose or fructose) and for small intestinal bacterial overgrowth.

2 commensal bacteria and prevented intestinal bacterial overgrowth.

3 teropathy resembles that seen in small-bowel bacterial overgrowth.

4 se mechanisms in the upper gut, resulting in bacterial overgrowth.

5 B12; thwarts enteric infection; and prevents bacterial overgrowth.

6 tential morbidity factor in ileus is luminal bacterial overgrowth.

7 pulsion with prokinetics, and suppression of bacterial overgrowth.

8 iciency states, and, frequently, small bowel bacterial overgrowth.

9 meprazole may predispose to small intestinal bacterial overgrowth.

10 uction, ulcers, gastroesophageal reflux, and bacterial overgrowth.

11 r fructose intolerance, and small intestinal bacterial overgrowth.

12 ith cirrhosis, can contribute to small-bowel bacterial overgrowth.

13 Bacterial overgrowth, alteration of the mucosal barrier

14 ntial role of mast cells; IBS as a result of bacterial overgrowth and altered gastrointestinal microb

15 The relation between bacterial overgrowth and altered intestinal motility gat

16 Small intestinal bacterial overgrowth and compositional changes of intest

17 ora into the small bowel or small intestinal bacterial overgrowth and discuss the effects of bacteria

18 Muc2(-/-) mice are protected from intestinal bacterial overgrowth and dysbiosis in response to alcoho

19 lcohol feeding is associated with intestinal bacterial overgrowth and enteric dysbiosis.

20 It also protects against bacterial overgrowth and enteric infection, including pr

21 Additionally, small intestinal bacterial overgrowth and Helicobacter pylori infection a

22 tions independently contribute to intestinal bacterial overgrowth and inflammation.

23 e acid levels in the gut are associated with bacterial overgrowth and inflammation.

24 es involved in enteroprotection and inhibits bacterial overgrowth and mucosal injury in ileum caused

25 ty liver disease (NAFLD), develop intestinal bacterial overgrowth and overexpress tumor necrosis fact

26 litis, other enteric infections, small bowel bacterial overgrowth and possibly spontaneous bacterial

27 subsequent phagocytic activity, resulting in bacterial overgrowth and translocation to the bloodstrea

28 as well as predispose to enteric infection, bacterial overgrowth, and gastric malignancy.

29 ially restored Reg3g protein levels, reduced bacterial overgrowth, and lessened alcoholic steatohepat

30 ia and osteopenia, cardiovascular disorders, bacterial overgrowth, and nutritional deficiencies.

31 ) mouse small intestine, and we hypothesized bacterial overgrowth as a possible cause.

32 discriminate between elevated cell death and bacterial overgrowth as potential mediators of mortality

33 t evaluate breath tests for small intestinal bacterial overgrowth, as they are not part of a standard

34 Oro-caecal transit time (OCTT) and bacterial overgrowth (BO) have been evaluated with H2 br

35 ibitors (PPIs) can contribute to small-bowel bacterial overgrowth, but no study has investigated the

36 ntation will require resolution of potential bacterial overgrowth during storage.

37 mmune activation promoted by products of gut bacterial overgrowth/dysbiosis and altered intestinal ba

38 and certain medications as well as prevents bacterial overgrowth, enteric infection, and possibly co

39 , calcium, vitamin B(12) as well as prevents bacterial overgrowth, enteric infection, and possibly fo

40 oorganisms and may play a role in preventing bacterial overgrowth, enteric infection, and possibly sp

41 o kills ingested microorganisms and prevents bacterial overgrowth, enteric infection, and possibly sp

42 gastrointestinal motility, permeability and bacterial overgrowth in cirrhosis.

43 The role of bacterial overgrowth in intestinal inflammation in CF wa

44 While interest in small intestinal bacterial overgrowth in irritable bowel syndrome continu

45 While interest in bacterial overgrowth in irritable bowel syndrome continu

46 The role of bacterial overgrowth in irritable bowel syndrome require

47 These data suggest that bacterial overgrowth in the CF mouse small intestine has

48 Proton pump inhibitors (PPIs) predispose to bacterial overgrowth in the gut.

49 rol animals were noted to have gram-negative bacterial overgrowth in the proximal bowel.

50 Bacterial overgrowth in the stomach caused by decreased

51 Bacterial overgrowth in the stomach may occur under cond

52 s) and taxa associated with gastrointestinal bacterial overgrowth (increased Micrococcaceae and Staph

53 lux disease, gastroparesis, small intestinal bacterial overgrowth, intestinal pseudo-obstruction, mal

54 Intestinal bacterial overgrowth is common in patients with alcoholi

55 Small intestinal bacterial overgrowth is one of the causes suggested for

56 Prior gastroenteritis and small intestinal bacterial overgrowth may be important for treatment of i

57 Reduced species diversity and bacterial overgrowth of bacteroidetes were identified as

58 Here Llorente et al. show that PPIs induce bacterial overgrowth of enterococci, which, in turn, exa

59 Acid-suppression use results in gastric bacterial overgrowth of genera including Staphylococcus

60 gen pump blocking agent (omeprazole) develop bacterial overgrowth of the small intestine.

61 chlorhydria in atrophic gastritis results in bacterial overgrowth of the stomach and small intestine,

62 terial overgrowth and discuss the effects of bacterial overgrowth on the human host in acute pancreat

63 ecause of increased intestinal permeability, bacterial overgrowth, or impaired clearance of microbial

64 Internal fistula, vascular complications, bacterial overgrowth, osteoporosis and renal lithiasis r

65 We tested the hypothesis that this bacterial overgrowth produces menaquinones, which would

66 The bacterial overgrowth rate was 7.0% for the MB/BacT versu

67 4.1 days for M. avium [mean values]) and the bacterial overgrowth rate was somewhat higher, the decre

68 Our data support the hypothesis that bacterial overgrowth results in the synthesis and absorp

69 Small intestinal bacterial overgrowth (SIBO) and changes in body composit

70 The concept of small intestinal bacterial overgrowth (SIBO) arose in the context of mald

71 Small intestinal bacterial overgrowth (SIBO) has been hypothesized to pla

72 Small intestinal bacterial overgrowth (SIBO) has been implicated in sympt

73 Small intestinal bacterial overgrowth (SIBO) is a condition of unknown pr

74 We find that small intestinal bacterial overgrowth (SIBO) is extremely common (>80%) i

75 to hydrogen breath testing, small intestinal bacterial overgrowth (SIBO) is now commonly diagnosed am

76 d bacterial composition and small intestinal bacterial overgrowth (SIBO) may be associated with irrit

77 The possibility that small intestinal bacterial overgrowth (SIBO) may explain bloating in IBS

78 IBS is not well-understood, small intestinal bacterial overgrowth (SIBO) or other abnormalities in th

79 Small intestinal bacterial overgrowth (SIBO) was originally described as

80 ine insufficiency (PEI) and small intestinal bacterial overgrowth (SIBO) was systematically assessed

81 bscores, breath testing for small intestinal bacterial overgrowth (SIBO), and the Patient Assessment

82 review recent literature on small intestinal bacterial overgrowth (SIBO).

83 improvement of symptoms of small intestinal bacterial overgrowth (SIBO).

84 epithelial deformation was shown to trigger bacterial overgrowth similar to that observed in patient

85 mproving the specificity of breath tests for bacterial overgrowth; small bowel enteroscopy; early dia

86 There are various methods for detecting bacterial overgrowth, the simplest of which is breath te

87 A salutary effect upon bacterial overgrowth was also noted.

88 difference after 1 day or 1 week, intestinal bacterial overgrowth was observed in the gastrointestina

89 nutritional status, absorptive capacity, and bacterial overgrowth were conducted 6 weeks after resect

90 Intraduodenal fatty acids (FA) and bacterial overgrowth, which generate short-chain FAs (SC

91 Disadvantageous profiles included bacterial overgrowth with neutrophilic inflammation, mic

92 hat this infection risk results from gastric bacterial overgrowth with subsequent seeding of the lung

93 ions included gastric ulceration, intestinal bacterial overgrowth with villous atrophy, and rectal pr

94 n is accompanied by intestinal dysbiosis and bacterial overgrowth, yet little is known about the fact